BRIEF published on 03/26/2025 at 14:40, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Position Disclosure Takeover Code Vanguard Group Direct Line Insurance Aviva
PRESS RELEASE published on 03/26/2025 at 14:35, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.37% interest in Direct Line Insurance Group plc as of 25th March 2025 The Vanguard Group Financial Disclosure Interest Disclosure Direct Line Insurance Group Plc Stock Holdings
BRIEF published on 03/25/2025 at 15:07, 1 year 5 months ago The Vanguard Group Discloses Stake in Direct Line Insurance Group Takeover Code Vanguard Group Securities Transactions Shareholding Disclosure Direct Line Insurance
BRIEF published on 03/25/2025 at 15:07, 1 year 5 months ago Le groupe Vanguard révèle sa participation dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Opérations Sur Titres Divulgation Des Actions Assurance Direct Line
PRESS RELEASE published on 03/25/2025 at 15:02, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC The Vanguard Group, Inc. discloses 5.36% ownership in Direct Line Insurance Group PLC. Details of securities holdings provided in Form 8.3 Form 8.3 Vanguard Group Ownership Disclosure Direct Line Insurance Securities Holdings
BRIEF published on 03/24/2025 at 14:27, 1 year 5 months ago Le groupe Vanguard révèle ses principaux intérêts dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Actions Négociation Financière Ligne Directe
BRIEF published on 03/24/2025 at 14:27, 1 year 5 months ago The Vanguard Group Discloses Key Interests in Direct Line Insurance Group Takeover Code Vanguard Group Shareholding Disclosure Financial Trading Direct Line
PRESS RELEASE published on 03/24/2025 at 14:22, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.37% ownership in Direct Line Insurance Group plc on 21 March 2025 Vanguard Group Ownership Disclosure Direct Line Insurance March 2025 5.37%
BRIEF published on 03/21/2025 at 15:49, 1 year 5 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Négociation D'actions Assurance Direct Line Divulgations De Participation
BRIEF published on 03/21/2025 at 15:49, 1 year 5 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Takeover Code Vanguard Group Direct Line Insurance Share Trading Stake Disclosures
Published on 09/11/2026 at 04:00, 6 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 35 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 20 minutes ago Availability of the 2026 Interim Financial Report
